Clopidogrel

General

Type : Not A\/B H target || Drug || Pyridine

Chemical_Nomenclature : methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate

Canonical SMILES : COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3

InChI : InChI=1S\/C16H16ClNO2S\/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14\/h2-5,7,9,15H,6,8,10H2,1H3\/t15-\/m0\/s1

InChIKey : GKTWGGQPFAXNFI-HNNXBMFYSA-N

Other name(s) : Plavix,     Zyllt,     (S)-Clopidogrel,     CHEMBL1771


MW : 321.81

Formula : C16H16ClNO2S

CAS_number : 113665-84-2

PubChem :

UniChem :

Iuphar :

Target

Families : Carb_B_Chordata

References (34)

Title : Is Genetic Variability in Carboxylesterase-1 and Carboxylesterase-2 Drug Metabolism an Important Component of Personalized Medicine? - Laizure_2020_Xenobiotica_50_92
Author(s) : Laizure SC , Parker RB
Ref : Xenobiotica , 50 :92 , 2020
Abstract : Laizure_2020_Xenobiotica_50_92
ESTHER : Laizure_2020_Xenobiotica_50_92
PubMedSearch : Laizure_2020_Xenobiotica_50_92
PubMedID: 31601149

Title : Inhibition of Carboxylesterase-1 Alters Clopidogrel Metabolism and Disposition - Laizure_2020_Xenobiotica_50_245
Author(s) : Laizure SC , Hu ZY , Potter PM , Parker RB
Ref : Xenobiotica , 50 :245 , 2020
Abstract : Laizure_2020_Xenobiotica_50_245
ESTHER : Laizure_2020_Xenobiotica_50_245
PubMedSearch : Laizure_2020_Xenobiotica_50_245
PubMedID: 31039046

Title : Effects of the rs2244613 polymorphism of the CES1 gene on the antiplatelet effect of the receptor P2Y12 blocker clopidogrel - Mirzaev_2019_Drug.Metab.Pers.Ther_34_
Author(s) : Mirzaev KB , Osipova DV , Kitaeva EJ , Shprakh VV , Abdullaev SP , Andreev DA , Mumladze RB , Sychev DA
Ref : Drug Metab Pers Ther , 34 : , 2019
Abstract : Mirzaev_2019_Drug.Metab.Pers.Ther_34_
ESTHER : Mirzaev_2019_Drug.Metab.Pers.Ther_34_
PubMedSearch : Mirzaev_2019_Drug.Metab.Pers.Ther_34_
PubMedID: 31560647

Title : Interspecies variation of clopidogrel hydrolysis in liver microsomes from various manmmals - Wang_2019_Chem.Biol.Interact__108871
Author(s) : Wang YQ , Shang XF , Wang L , Zhang P , Zou LW , Song YQ , Hao DC , Fang SQ , Ge GB , Tang H
Ref : Chemico-Biological Interactions , :108871 , 2019
Abstract : Wang_2019_Chem.Biol.Interact__108871
ESTHER : Wang_2019_Chem.Biol.Interact__108871
PubMedSearch : Wang_2019_Chem.Biol.Interact__108871
PubMedID: 31669218

Title : Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects - Neuvonen_2018_Basic.Clin.Pharmacol.Toxicol_122_341
Author(s) : Neuvonen M , Tarkiainen EK , Tornio A , Hirvensalo P , Tapaninen T , Paile-Hyvarinen M , Itkonen MK , Holmberg MT , Karja V , Mannisto VT , Neuvonen PJ , Pihlajamaki J , Backman JT , Niemi M
Ref : Basic Clin Pharmacol Toxicol , 122 :341 , 2018
Abstract : Neuvonen_2018_Basic.Clin.Pharmacol.Toxicol_122_341
ESTHER : Neuvonen_2018_Basic.Clin.Pharmacol.Toxicol_122_341
PubMedSearch : Neuvonen_2018_Basic.Clin.Pharmacol.Toxicol_122_341
PubMedID: 28990360
Gene_locus related to this paper: human-CES1

Title : Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients - Xiao_2017_Sci.Rep_7_7244
Author(s) : Xiao FY , Luo JQ , Liu M , Chen BL , Cao S , Liu ZQ , Zhou HH , Zhou G , Zhang W
Ref : Sci Rep , 7 :7244 , 2017
Abstract : Xiao_2017_Sci.Rep_7_7244
ESTHER : Xiao_2017_Sci.Rep_7_7244
PubMedSearch : Xiao_2017_Sci.Rep_7_7244
PubMedID: 28775293
Gene_locus related to this paper: human-CES1

Title : A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms - Wang_2017_Drug.Metab.Dispos_45_1149
Author(s) : Wang X , Rida N , Shi J , Wu AH , Bleske BE , Zhu HJ
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 45 :1149 , 2017
Abstract : Wang_2017_Drug.Metab.Dispos_45_1149
ESTHER : Wang_2017_Drug.Metab.Dispos_45_1149
PubMedSearch : Wang_2017_Drug.Metab.Dispos_45_1149
PubMedID: 28838926
Gene_locus related to this paper: human-CES1

Title : Gambogic acid potentiates clopidogrel-induced apoptosis and attenuates irinotecan-induced apoptosis through down-regulating human carboxylesterase 1 and -2 - Ning_2016_Xenobiotica__1
Author(s) : Ning R , Wang XP , Zhan YR , Qi Q , Huang XF , Hu G , Guo QL , Liu W , Yang J
Ref : Xenobiotica , :1 , 2016
Abstract : Ning_2016_Xenobiotica__1
ESTHER : Ning_2016_Xenobiotica__1
PubMedSearch : Ning_2016_Xenobiotica__1
PubMedID: 26750665

Title : Liver Function is Associated With Response to Clopidogrel Therapy in Patients Undergoing Angioplasty and Stenting - Gremmel_2016_Angiology_67_835
Author(s) : Gremmel T , Mueller M , Koppensteiner R , Panzer S
Ref : Angiology , 67 :835 , 2016
Abstract : Gremmel_2016_Angiology_67_835
ESTHER : Gremmel_2016_Angiology_67_835
PubMedSearch : Gremmel_2016_Angiology_67_835
PubMedID: 26416820

Title : Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus - Sanford_2016_Pharmacogenet.Genomics_26_197
Author(s) : Sanford JC , Wang X , Shi J , Barrie ES , Wang D , Zhu HJ , Sadee W
Ref : Pharmacogenet Genomics , 26 :197 , 2016
Abstract : Sanford_2016_Pharmacogenet.Genomics_26_197
ESTHER : Sanford_2016_Pharmacogenet.Genomics_26_197
PubMedSearch : Sanford_2016_Pharmacogenet.Genomics_26_197
PubMedID: 26871237
Gene_locus related to this paper: human-CES1

Title : Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy - Wang_2015_Ther.Clin.Risk.Manag_11_449
Author(s) : Wang ZY , Chen M , Zhu LL , Yu LS , Zeng S , Xiang MX , Zhou Q
Ref : Ther Clin Risk Manag , 11 :449 , 2015
Abstract : Wang_2015_Ther.Clin.Risk.Manag_11_449
ESTHER : Wang_2015_Ther.Clin.Risk.Manag_11_449
PubMedSearch : Wang_2015_Ther.Clin.Risk.Manag_11_449
PubMedID: 25848291

Title : A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors - Cressman_2015_Br.J.Clin.Pharmacol_80_662
Author(s) : Cressman AM , Macdonald EM , Fernandes KA , Gomes T , Paterson JM , Mamdani MM , Juurlink DN
Ref : British Journal of Clinical Pharmacology , 80 :662 , 2015
Abstract : Cressman_2015_Br.J.Clin.Pharmacol_80_662
ESTHER : Cressman_2015_Br.J.Clin.Pharmacol_80_662
PubMedSearch : Cressman_2015_Br.J.Clin.Pharmacol_80_662
PubMedID: 25980448

Title : Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases - Fukami_2015_Eur.J.Pharm.Sci_78_47
Author(s) : Fukami T , Kariya M , Kurokawa T , Iida A , Nakajima M
Ref : Eur J Pharm Sci , 78 :47 , 2015
Abstract : Fukami_2015_Eur.J.Pharm.Sci_78_47
ESTHER : Fukami_2015_Eur.J.Pharm.Sci_78_47
PubMedSearch : Fukami_2015_Eur.J.Pharm.Sci_78_47
PubMedID: 26164127
Gene_locus related to this paper: human-AADAC , human-CES1 , human-CES2

Title : Carboxylesterase 1-Mediated Drug-Drug Interactions between Clopidogrel and Simvastatin - Wang_2015_Biol.Pharm.Bull_38_292
Author(s) : Wang X , Zhu HJ , Markowitz JS
Ref : Biol Pharm Bull , 38 :292 , 2015
Abstract : Wang_2015_Biol.Pharm.Bull_38_292
ESTHER : Wang_2015_Biol.Pharm.Bull_38_292
PubMedSearch : Wang_2015_Biol.Pharm.Bull_38_292
PubMedID: 25747989

Title : Carboxylesterase 1 c.428G>\;A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans - Tarkiainen_2015_Clin.Pharmacol.Ther_97_650
Author(s) : Tarkiainen EK , Holmberg MT , Tornio A , Neuvonen M , Neuvonen PJ , Backman JT , Niemi M
Ref : Clinical Pharmacology & Therapeutics , 97 :650 , 2015
Abstract : Tarkiainen_2015_Clin.Pharmacol.Ther_97_650
ESTHER : Tarkiainen_2015_Clin.Pharmacol.Ther_97_650
PubMedSearch : Tarkiainen_2015_Clin.Pharmacol.Ther_97_650
PubMedID: 25704243
Gene_locus related to this paper: human-CES1

Title : Multiple Cytochrome P450 Isoforms Are Involved in the Generation of a Pharmacologically Active Thiol Metabolite, whereas Paraoxonase 1 and Carboxylesterase 1 Catalyze the Formation of a Thiol Metabolite Isomer from Ticlopidine - Kim_2014_Drug.Metab.Dispos_42_141
Author(s) : Kim MJ , Jeong ES , Park JS , Lee SJ , Ghim JL , Choi CS , Shin JG , Kim DH
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 42 :141 , 2014
Abstract : Kim_2014_Drug.Metab.Dispos_42_141
ESTHER : Kim_2014_Drug.Metab.Dispos_42_141
PubMedSearch : Kim_2014_Drug.Metab.Dispos_42_141
PubMedID: 24170778
Gene_locus related to this paper: human-CES1

Title : The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease - Xie_2014_Pharmacogenet.Genomics_24_204
Author(s) : Xie C , Ding X , Gao J , Wang H , Hang Y , Zhang H , Zhang J , Jiang B , Miao L
Ref : Pharmacogenet Genomics , 24 :204 , 2014
Abstract : Xie_2014_Pharmacogenet.Genomics_24_204
ESTHER : Xie_2014_Pharmacogenet.Genomics_24_204
PubMedSearch : Xie_2014_Pharmacogenet.Genomics_24_204
PubMedID: 24535487

Title : Clopidogrel Bioactivation and Risk of Bleeding in Patients Cotreated With Angiotensin-Converting Enzyme Inhibitors After Myocardial Infarction: A Proof-of-Concept Study - Kristensen_2014_Clin.Pharmacol.Ther_96_713
Author(s) : Kristensen KE , Zhu HJ , Wang X , Gislason GH , Torp-Pedersen C , Rasmussen HB , Markowitz JS , Hansen PR
Ref : Clinical Pharmacology & Therapeutics , 96 :713 , 2014
Abstract : Kristensen_2014_Clin.Pharmacol.Ther_96_713
ESTHER : Kristensen_2014_Clin.Pharmacol.Ther_96_713
PubMedSearch : Kristensen_2014_Clin.Pharmacol.Ther_96_713
PubMedID: 25222620

Title : The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect - Merali_2014_Drug.Metabol.Drug.Interact_29_143
Author(s) : Merali Z , Ross S , Pare G
Ref : Drug Metabol Drug Interact , 29 :143 , 2014
Abstract : Merali_2014_Drug.Metabol.Drug.Interact_29_143
ESTHER : Merali_2014_Drug.Metabol.Drug.Interact_29_143
PubMedSearch : Merali_2014_Drug.Metabol.Drug.Interact_29_143
PubMedID: 24988246
Gene_locus related to this paper: human-CES2

Title : The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response - Lewis_2013_Pharmacogenet.Genomics_23_1
Author(s) : Lewis JP , Horenstein RB , Ryan K , O'Connell JR , Gibson Q , Mitchell BD , Tanner K , Chai S , Bliden KP , Tantry US , Peer CJ , Figg WD , Spencer SD , Pacanowski MA , Gurbel PA , Shuldiner AR
Ref : Pharmacogenet Genomics , 23 :1 , 2013
Abstract : Lewis_2013_Pharmacogenet.Genomics_23_1
ESTHER : Lewis_2013_Pharmacogenet.Genomics_23_1
PubMedSearch : Lewis_2013_Pharmacogenet.Genomics_23_1
PubMedID: 23111421
Gene_locus related to this paper: human-CES1

Title : Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation - Zhu_2013_J.Pharmacol.Exp.Ther_344_665
Author(s) : Zhu HJ , Wang X , Gawronski BE , Brinda BJ , Angiolillo DJ , Markowitz JS
Ref : Journal of Pharmacology & Experimental Therapeutics , 344 :665 , 2013
Abstract : Zhu_2013_J.Pharmacol.Exp.Ther_344_665
ESTHER : Zhu_2013_J.Pharmacol.Exp.Ther_344_665
PubMedSearch : Zhu_2013_J.Pharmacol.Exp.Ther_344_665
PubMedID: 23275066
Gene_locus related to this paper: human-CES1

Title : The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro - Ancrenaz_2012_Br.J.Pharmacol_166_2362
Author(s) : Ancrenaz V , Desmeules J , James RW , Fontana P , Reny JL , Dayer P , Daali Y
Ref : British Journal of Pharmacology , 166 :2362 , 2012
Abstract : Ancrenaz_2012_Br.J.Pharmacol_166_2362
ESTHER : Ancrenaz_2012_Br.J.Pharmacol_166_2362
PubMedSearch : Ancrenaz_2012_Br.J.Pharmacol_166_2362
PubMedID: 22428615

Title : Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver - Sato_2012_Drug.Metab.Dispos_40_902
Author(s) : Sato Y , Miyashita A , Iwatsubo T , Usui T
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 40 :902 , 2012
Abstract : Sato_2012_Drug.Metab.Dispos_40_902
ESTHER : Sato_2012_Drug.Metab.Dispos_40_902
PubMedSearch : Sato_2012_Drug.Metab.Dispos_40_902
PubMedID: 22293119

Title : Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis - Reny_2012_J.Thromb.Haemost_10_1242
Author(s) : Reny JL , Combescure C , Daali Y , Fontana P
Ref : J Thromb Haemost , 10 :1242 , 2012
Abstract : Reny_2012_J.Thromb.Haemost_10_1242
ESTHER : Reny_2012_J.Thromb.Haemost_10_1242
PubMedSearch : Reny_2012_J.Thromb.Haemost_10_1242
PubMedID: 22520065

Title : Paraoxonase-1 is a major determinant of clopidogrel efficacy - Bouman_2011_Nat.Med_17_110
Author(s) : Bouman HJ , Schomig E , van Werkum JW , Velder J , Hackeng CM , Hirschhauser C , Waldmann C , Schmalz HG , ten Berg JM , Taubert D
Ref : Nat Med , 17 :110 , 2011
Abstract : Bouman_2011_Nat.Med_17_110
ESTHER : Bouman_2011_Nat.Med_17_110
PubMedSearch : Bouman_2011_Nat.Med_17_110
PubMedID: 21170047

Title : Paraoxonase-1 and clopidogrel efficacy -
Author(s) : Camps J , Joven J , Mackness B , Mackness MI , Tawfik DS , Draganov DI , Costa LG , Paragh G , Seres I , Horke S , James RW , Hernandez AF , Reddy ST , Shih DM , Navab M , Rochu D , Aviram M
Ref : Nat Med , 17 :1041 , 2011
PubMedID: 21900915

Title : Paraoxonase-1 and clopidogrel efficacy -
Author(s) : Cuisset T , Morange PE , Quilici J , Bonnet JL , Gachet C , Alessi MC
Ref : Nat Med , 17 :1039\; author reply 1042 , 2011
PubMedID: 21900913

Title : Paraoxonase-1 and clopidogrel efficacy -
Author(s) : Dansette PM , Rosi J , Bertho G , Mansuy D
Ref : Nat Med , 17 :1040 , 2011
PubMedID: 21900914

Title : Influence of high-density lipoprotein and paraoxonase-1 on platelet reactivity in patients with acute coronary syndromes receiving clopidogrel therapy - Tselepis_2011_J.Thromb.Haemost_9_2371
Author(s) : Tselepis AD , Tsoumani ME , Kalantzi KI , Dimitriou AA , Tellis CC , Goudevenos IA
Ref : J Thromb Haemost , 9 :2371 , 2011
Abstract : Tselepis_2011_J.Thromb.Haemost_9_2371
ESTHER : Tselepis_2011_J.Thromb.Haemost_9_2371
PubMedSearch : Tselepis_2011_J.Thromb.Haemost_9_2371
PubMedID: 22008470

Title : Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans - Farid_2010_J.Clin.Pharmacol_50_126
Author(s) : Farid NA , Kurihara A , Wrighton SA
Ref : Journal of Clinical Pharmacology , 50 :126 , 2010
Abstract : Farid_2010_J.Clin.Pharmacol_50_126
ESTHER : Farid_2010_J.Clin.Pharmacol_50_126
PubMedSearch : Farid_2010_J.Clin.Pharmacol_50_126
PubMedID: 19948947

Title : A comparison of the metabolism of clopidogrel and prasugrel - Laizure_2010_Expert.Opin.Drug.Metab.Toxicol_6_1417
Author(s) : Laizure SC , Parker RB
Ref : Expert Opin Drug Metab Toxicol , 6 :1417 , 2010
Abstract : Laizure_2010_Expert.Opin.Drug.Metab.Toxicol_6_1417
ESTHER : Laizure_2010_Expert.Opin.Drug.Metab.Toxicol_6_1417
PubMedSearch : Laizure_2010_Expert.Opin.Drug.Metab.Toxicol_6_1417
PubMedID: 20839914

Title : A possible mechanism for the differences in efficiency and variability of active metabolite formation from thienopyridine antiplatelet agents, prasugrel and clopidogrel - Hagihara_2009_Drug.Metab.Dispos_37_2145
Author(s) : Hagihara K , Kazui M , Kurihara A , Yoshiike M , Honda K , Okazaki O , Farid NA , Ikeda T
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 37 :2145 , 2009
Abstract : Hagihara_2009_Drug.Metab.Dispos_37_2145
ESTHER : Hagihara_2009_Drug.Metab.Dispos_37_2145
PubMedSearch : Hagihara_2009_Drug.Metab.Dispos_37_2145
PubMedID: 19704027

Title : Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel - Shi_2006_J.Pharmacol.Exp.Ther_319_1477
Author(s) : Shi D , Yang J , Yang D , LeCluyse EL , Black C , You L , Akhlaghi F , Yan B
Ref : Journal of Pharmacology & Experimental Therapeutics , 319 :1477 , 2006
Abstract : Shi_2006_J.Pharmacol.Exp.Ther_319_1477
ESTHER : Shi_2006_J.Pharmacol.Exp.Ther_319_1477
PubMedSearch : Shi_2006_J.Pharmacol.Exp.Ther_319_1477
PubMedID: 16966469

Title : Atorvastatin-clopidogrel interaction -
Author(s) : Martin PT , Denman R
Ref : Circulation , 107 :e223\; author reply e223 , 2003
PubMedID: 12821599